In contrast, the frequency of CD8+CD56+-NKT cells, notably on CD8+CD56+CD3+-NKT CD8 cell population, was higher in the COVID-19 cohort, regardless of their VRS period. The gene discussed is NCAM1; the disease is COVID-19.